The Impact of Preeclampsia in Lupus Nephritis

References

• National High Blood Pressure Education Program Working Group. Report of the national high blood pressure education program working group on high blood pressure in pregnancy. Am J Obstet Gynecol. 2000;183(1):S1–22.
   PubMedGoogle Scholar
• American College of Obstetricians and Gynecologists. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol. 2013;122:1122–1131.
   PubMed Web of Science ®Google Scholar
• Phipps E, Prasanna D, Brima W, et al. Preeclampsia: updates in Pathogenesis, Definitions, and Guidelines. Clin J Am Soc Nephrol. 2016;11(6):1102–1113.
   PubMed Web of Science ®Google Scholar
• Gaber LW, Spargo BH, Lindheimer MD. Renal pathology in pre-eclampsia. Bailliere’s Clin Obstet Gynaecol. 1987;1(4):971–995.
   PubMedGoogle Scholar
• Spargo BH, Lichtig C, Luger AM, et al. The renal lesion in preeclampsia. Perspect Nephrol Hypertens. 1976;5:129–137.
   PubMedGoogle Scholar
• Mintz G, Niz J, Gutierrez G, et al. Prospective study of pregnancy in systemic lupus erythematosus. Results of a multidisciplinary approach. J Rheumatol. 1986;13(4):732–739.
   PubMed Web of Science ®Google Scholar
• Wilkerson RG, Ogunbodede AC. Hypertensive Disorders of Pregnancy. Emerg Med Clin North Am. 2019;37(2):301–316.
   PubMed Web of Science ®Google Scholar
• Sibai BM, Lindheimer M, Hauth J, et al. Risk factors for preeclampsia, abruptio placentae, and adverse neonatal outcomes among women with chronic hypertension. National institute of child health and human development network of maternal-fetal medicine units. N Engl J Med. 1998;339(10):667–671.
   PubMed Web of Science ®Google Scholar
• Ferrer RL, Sibai BM, Mulrow CD, et al. Management of mild chronic hypertension during pregnancy: a review. Obstet Gynecol. 2000;96(5 Pt 2):849–860.
   PubMedGoogle Scholar
• Shah S, Gupta A. Hypertensive disorders of pregnancy. Cardiol Clin. 2019;37(3):345–354.
   PubMedGoogle Scholar
• Gestational hypertension and preeclampsia: ACOG Practice Bulletin, Number 222. Obstet Gynecol. 2020;135(6):e237–60.
   PubMed Web of Science ®Google Scholar
• Martin JN, Rinehart BK, May WL, et al. The spectrum of severe preeclampsia: comparative analysis by HELLP (hemolysis, elevated liver enzyme levels, and low platelet count) syndrome classification. Am J Obstet Gynecol. 1999;180(6):1373–1384.
   PubMed Web of Science ®Google Scholar
• Liu S, Joseph KS, Liston RM, et al. Incidence, risk factors, and associated complications of eclampsia. Obstet Gynecol. 2011;118(5):987–994.
   PubMed Web of Science ®Google Scholar
• Tranquilli AL, Dekker G, Magee L, et al. The classification, diagnosis and management of the hypertensive disorders of pregnancy: a revised statement from the ISSHP. Pregnancy Hypertens. 2014;4(2):97–104.
   PubMed Web of Science ®Google Scholar
• Mol BWJ, Roberts CT, Thangaratinam S, et al. Pre-eclampsia. Lancet. 2016;387(10022):999–1011.
   PubMed Web of Science ®Google Scholar
• Redman C. Pre-eclampsia: a complex and variable disease. Pregnancy Hypertens. 2014;4:241–242.
   Google Scholar
• Piccoli GB, Cabiddu G, Castellino S, et al. A best practice position statement on the role of the nephrologist in the prevention and follow-up of preeclampsia: the Italian study group on kidney and pregnancy. J Nephrol. 2017;30(3):307–317.
   PubMedGoogle Scholar
• Al-Safi Z, Imudia AN, Filetti LC, et al. Delayed postpartum preeclampsia and eclampsia: demographics, clinical course, and complications. Obstet Gynecol. 2011;118(5):1102–1107.
   PubMed Web of Science ®Google Scholar
• Abalos E, Cuesta C, Grosso AL, et al. Global and regional estimates of preeclampsia and eclampsia: a systematic review. Eur J Obstet Gynecol Reprod Biol. 2013;170(1):1–7.
   PubMed Web of Science ®Google Scholar
• Kongwattanakul K, Saksiriwuttho P, Chaiyarach S, et al. Incidence, characteristics, maternal complications, and perinatal outcomes associated with preeclampsia with severe features and HELLP syndrome. Int J Womens Health. 2018;10:371–377.
   PubMed Web of Science ®Google Scholar
• English FA, Kenny LC, McCarthy FP. Risk factors and effective management of preeclampsia. Integr Blood Press Control. 2015;8:7–12.
   PubMed Web of Science ®Google Scholar
• Bartsch E, Medcalf KE, Park AL, et al. Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies. BMJ. 2016;353:i1753.
   PubMed Web of Science ®Google Scholar
• Bianco A, Stone J, Lynch L, et al. Pregnancy outcome at age 40 and older. Obstet Gynecol. 1996;87(6):917–922.
   PubMed Web of Science ®Google Scholar
• Saftlas AF, Olson DR, Franks AL, et al. Epidemiology of preeclampsia and eclampsia in the United States, 1979-1986. Am J Obstet Gynecol. 1990;163(2):460–465.
   PubMed Web of Science ®Google Scholar
• Coonrod D, Hickok DE, Zhu K, et al. Risk factors for preeclampsia in twin pregnancies: a population-based cohort study. Obstet Gynecol. 1995;85(5):645–650.
   PubMedGoogle Scholar
• Arngrimsson R, Björnsson S, Geirsson RT, et al. Genetic and familial predisposition to eclampsia and pre-eclampsia in a defined population. Br J Obstet Gynaecol. 1990;97(9):762.
   PubMedGoogle Scholar
• Cincotta RB, Brennecke SP. Family history of pre-eclampsia as a predictor for pre-eclampsia in primigravidas. Int J Gynaecol Obstet. 1998;60(1):23–27.
   PubMed Web of Science ®Google Scholar
• Garner PR, D’Alton ME, Dudley DK, et al. Preeclampsia in diabetic pregnancies. Am J Obstet Gynecol. 1990;163(2):505–508.
   PubMed Web of Science ®Google Scholar
• Yasuda M, Takakuwa K, Tokunaga A, et al. Prospective studies of the association between anticardiolipin antibody and outcome of pregnancy. Obstet Gynecol. 1995;86(4):555–559.
   PubMedGoogle Scholar
• Teal EN, Appiagyei A, Sheffield-Abdullah K, et al. Differences in disease severity and delivery gestational age between black and white patients with hypertensive disorders of pregnancy. Pregnancy Hypertens. 2022;28:88–93.
   PubMedGoogle Scholar
• Gaillard R, Steegers EAP, Hofman A, et al. Associations of maternal obesity with blood pressure and the risks of gestational hypertensive disorders. The Generation R Study. J Hypertens. 2011;29(5):937–944.
   PubMed Web of Science ®Google Scholar
• Anderson NH, Sadler LC, Stewart AW, et al. Ethnicity, body mass index and risk of pre-eclampsia in a multiethnic New Zealand population. Aust N Z J Obstet Gynaecol. 2012;52(6):552–558.
   PubMedGoogle Scholar
• Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ. 2005;330(7491):565.
   PubMed Web of Science ®Google Scholar
• Savvidou MD, Karanastasi E, Skentou C, et al. Twin chorionicity and pre-eclampsia. Ultrasound Obstet Gynecol. 2001;18(3):228–231.
   PubMedGoogle Scholar
• Ponticelli C, Zaina B, Moroni G. Planned pregnancy in kidney transplantation. A calculated risk. J Pers Med. 2021;11. DOI:https://doi.org/10.3390/jpm12010011
   Google Scholar
• Piccoli GB, Attini R, Cabiddu G, et al. Maternal-foetal outcomes in pregnant women with glomerulonephritides. Are all glomerulonephritides alike in pregnancy? J Autoimmun. 2017;79:91–98.
   PubMedGoogle Scholar
• Bramham K, Briley AL, Seed PT, et al. Pregnancy outcome in women with chronic kidney disease: a prospective cohort study. Reprod Sci. 2011;18(7):623–630.
   PubMed Web of Science ®Google Scholar
• Sivasuthan G, Dahwa R, John GT, et al. Dialysis and pregnancy in end stage kidney disease associated with lupus nephritis. Case Rep Med. 2013;2013:923581.
   PubMedGoogle Scholar
• Zhang -J-J, Ma -X-X, Hao L, et al. A systematic review and meta-analysis of outcomes of pregnancy in CKD and CKD outcomes in pregnancy. Clin J Am Soc Nephrol. 2015;10(11):1964–1978.
   PubMed Web of Science ®Google Scholar
• Chakravarty EF, Colón I, Langen ES, et al. Factors that predict prematurity and preeclampsia in pregnancies that are complicated by systemic lupus erythematosus. Am J Obstet Gynecol. 2005;192(6):1897–1904.
   PubMed Web of Science ®Google Scholar
• Boyd HA, Basit S, Harpsøe MC, et al. Inflammatory bowel disease and risk of adverse pregnancy outcomes. PLoS One. 2015;10(6):e0129567.
   PubMedGoogle Scholar
• Bandoli G, Palmsten K, Forbess Smith CJ, et al. A review of systemic corticosteroid use in pregnancy and the risk of select pregnancy and birth outcomes. Rheum Dis Clin North Am. 2017;43(3):489–502.
   PubMed Web of Science ®Google Scholar
• Palmsten K, Hernández-Díaz S, Kuriya B, et al. Use of disease-modifying antirheumatic drugs during pregnancy and risk of preeclampsia. Arthritis Care Res (Hoboken). 2012;64(11):1730–1738.
   PubMedGoogle Scholar
• Paziana K, Del Monaco M, Cardonick E, et al. Ciclosporin use during pregnancy. Drug Saf. 2013;36(5):279–294.
   PubMed Web of Science ®Google Scholar
• Le HL, Francke MI, Andrews LM, et al. Usage of tacrolimus and mycophenolic acid during conception, pregnancy, and lactation, and its implications for therapeutic drug monitoring: a systematic critical review. Ther Drug Monit. 2020;42(4):518–531.
   PubMed Web of Science ®Google Scholar
• Gong X, Li J, Yan J, et al. Pregnancy outcomes in female patients exposed to cyclosporin-based versus tacrolimus-based immunosuppressive regimens after liver/kidney transplantation: a systematic review and meta-analysis. J Clin Pharm Ther. 2021;46(3):744–753.
   PubMedGoogle Scholar
• Moroni G, Doria A, Giglio E, et al. Maternal outcome in pregnant women with lupus nephritis. A prospective multicenter study. J Autoimmun. 2016;74:194–200.
   PubMed Web of Science ®Google Scholar
• Bramham K, Hunt BJ, Bewley S, et al. Pregnancy outcomes in systemic lupus erythematosus with and without previous nephritis. J Rheumatol. 2011;38(9):1906–1913.
   PubMed Web of Science ®Google Scholar
• Lian X-J, Fan L, Xia X, et al. Fetal and maternal outcome in patients with active lupus nephritis: comparison between new-onset and pre-existing lupus nephritis. BMC Nephrol. 2021;22(1):419.
   PubMed Web of Science ®Google Scholar
• Chen D, Lao M, Zhang J, et al. Fetal and maternal outcomes of planned pregnancy in patients with systemic lupus erythematosus: a retrospective multicenter study. J Immunol Res. 2018;2018:2413637.
   PubMedGoogle Scholar
• Smyth A, Oliveira GHM, Lahr BD, et al., A systematic review and meta-analysis of pregnancy outcomes in patients with systemic lupus erythematosus and lupus nephritis. Clin J Am Soc Nephrol. 5(11): 2060–2068. 2010.
   PubMed Web of Science ®Google Scholar
• Fischer-Betz R, Specker C, Brinks R, et al., Low risk of renal flares and negative outcomes in women with lupus nephritis conceiving after switching from mycophenolate mofetil to azathioprine. Rheumatology (Oxford). 52(6): 1070–1076. 2013.
   PubMed Web of Science ®Google Scholar
• Kaufmann P, Black S, Huppertz B. Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol Reprod. 2003;69(1):1–7.
   PubMed Web of Science ®Google Scholar
• Chappell LC, Cluver CA, Kingdom J, et al. Pre-eclampsia. Lancet. 2021;398(10297):341–354.
   PubMed Web of Science ®Google Scholar
• Vangrieken P, Al-Nasiry S, Janssen GMJ, et al. The direct and sustained consequences of severe placental hypoxia on vascular contractility. PLoS One. 2018;13(8):e0202648.
   PubMedGoogle Scholar
• Rana S, Lemoine E, Granger JP, et al. Preeclampsia: pathophysiology, Challenges, and Perspectives. Circ Res. 2019;124(7):1094–1112.
   PubMed Web of Science ®Google Scholar
• Schuster J, Cheng S-B, Padbury J, et al. Placental extracellular vesicles and pre-eclampsia. Am J Reprod Immunol. 2021;85(2):e13297.
   PubMedGoogle Scholar
• Maynard SE, Min J-Y, Merchan J, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003;111(5):649–658.
   PubMed Web of Science ®Google Scholar
• Redman CW, Sargent IL, Staff AC. IFPA Senior Award Lecture: making sense of pre-eclampsia - two placental causes of preeclampsia? Placenta. 2014;35 Suppl:S20–5.
   PubMedGoogle Scholar
• Amaral LM, Cunningham MW, Cornelius DC, et al. Preeclampsia: long-term consequences for vascular health. Vasc Health Risk Manag. 2015;11:403–415.
   PubMed Web of Science ®Google Scholar
• Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet. 2005;365(9461):785–799.
   PubMed Web of Science ®Google Scholar
• Karumanchi SA, Maynard SE, Stillman IE, et al. Preeclampsia: a renal perspective. Kidney Int. 2005;67(6):2101–2113.
   PubMed Web of Science ®Google Scholar
• Thangaratinam S, Gallos ID, Meah N, et al. How accurate are maternal symptoms in predicting impending complications in women with preeclampsia? A systematic review and meta-analysis. Acta Obstet Gynecol Scand. 2011;90(6):564–573.
   PubMed Web of Science ®Google Scholar
• Zeeman GG. Neurologic complications of pre-eclampsia. Semin Perinatol. 2009;33(3):166–172.
   PubMed Web of Science ®Google Scholar
• Roos NM, Wiegman MJ, Jansonius NM, et al. Visual disturbances in (pre)eclampsia. Obstet Gynecol Surv. 2012;67(4):242–250.
   PubMed Web of Science ®Google Scholar
• Bauer ST, Cleary KL. Cardiopulmonary complications of pre-eclampsia. Semin Perinatol. 2009;33(3):158–165.
   PubMedGoogle Scholar
• Walters BNJ. Preeclamptic angina–a pathognomonic symptom of preeclampsia. Hypertens Pregnancy. 2011;30(2):117–124.
   PubMed Web of Science ®Google Scholar
• Vaught AJ, Kovell LC, Szymanski LM, et al. Acute cardiac effects of severe pre-eclampsia. J Am Coll Cardiol. 2018;72(1):1–11.
   PubMed Web of Science ®Google Scholar
• Altman D, Carroli G, Duley L, et al. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet. 2002;359:1877–1890.
   PubMed Web of Science ®Google Scholar
• Coetzee EJ, Dommisse J, Anthony J. A randomised controlled trial of intravenous magnesium sulphate versus placebo in the management of women with severe pre-eclampsia. Br J Obstet Gynaecol. 1998;105(3):300–303.
   PubMedGoogle Scholar
• Cnossen JS, de Ruyter-Hanhijärvi H, van der Post JAM, et al. Accuracy of serum uric acid determination in predicting pre-eclampsia: a systematic review. Acta Obstet Gynecol Scand. 2006;85(5):519–525.
   PubMed Web of Science ®Google Scholar
• Stillman IE, Karumanchi SA. The glomerular injury of preeclampsia. J Am Soc Nephrol. 2007;18(8):2281–2284.
   PubMed Web of Science ®Google Scholar
• Weening JJ, D’Agati VD, Schwartz MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol. 2004;15(2):241–250.
   PubMed Web of Science ®Google Scholar
• Sudo M, Yoshita K, Ito Y, et al. Histopathological features of kidney and renal prognosis in patients with preeclampsia. Pregnancy Hypertens. 2021;25:75–80.
   PubMedGoogle Scholar
• Cnossen JS, Morris RK, ter Riet G, et al. Use of uterine artery Doppler ultrasonography to predict pre-eclampsia and intrauterine growth restriction: a systematic review and bivariable meta-analysis. CMAJ. 2008;178(6):701–711.
   PubMed Web of Science ®Google Scholar
• Sotiriadis A, Hernandez-Andrade E, da Silva Costa F, et al. ISUOG practice guidelines: role of ultrasound in screening for and follow-up of pre-eclampsia. Ultrasound Obstet Gynecol. 2019;53(1):7–22.
   PubMed Web of Science ®Google Scholar
• Oviasu E, Hicks J, Cameron JS. The outcome of pregnancy in women with lupus nephritis. Lupus. 1991;1(1):19–25.
   PubMedGoogle Scholar
• Moroni G, Ponticelli C. Important considerations in pregnant patients with lupus nephritis. Expert Rev Clin Immunol. 2018;14(6):489–498.
   PubMed Web of Science ®Google Scholar
• Petri M. Pregnancy and systemic lupus erythematosus. Best Pract Res Clin Obstet Gynaecol. 2020;64:24–30.
   PubMed Web of Science ®Google Scholar
• Tani C, Zucchi D, Haase I, et al. Are remission and low disease activity state ideal targets for pregnancy planning in systemic lupus erythematosus? A multicentre study. Rheumatology (Oxford). 2021;60(1):5610–5619.
   PubMedGoogle Scholar
• Ponticelli C, Moroni G. Flares in lupus nephritis: incidence, impact on renal survival and management. Lupus. 1998;7(9):635–638.
   PubMedGoogle Scholar
• Moroni G, Quaglini S, Maccario M, et al. “Nephritic flares” are predictors of bad long-term renal outcome in lupus nephritis. Kidney Int. 1996;50(6):2047–2053.
   PubMed Web of Science ®Google Scholar
• Moroni G, Quaglini S, Gallelli B, et al. The long-term outcome of 93 patients with proliferative lupus nephritis. Nephrol Dial Transplant. 2007;22(9):2531–2539.
   PubMed Web of Science ®Google Scholar
• Buyon JP, Kim MY, Guerra MM, et al. Kidney outcomes and risk factors for nephritis (Flare/De Novo) in a multiethnic cohort of pregnant patients with lupus. Clin J Am Soc Nephrol. 2017;12:940–946.
   PubMed Web of Science ®Google Scholar
• Imbasciati E, Tincani A, Gregorini G, et al. Pregnancy in women with pre-existing lupus nephritis: predictors of fetal and maternal outcome. Nephrol Dial Transplant. 2009;24(2):519–525.
   PubMed Web of Science ®Google Scholar
• Yang H, Liu H, Xu D, et al. Pregnancy-related systemic lupus erythematosus: clinical features, outcome and risk factors of disease flares–a case control study. PLoS One. 2014;9(8):e104375.
   PubMed Web of Science ®Google Scholar
• Clowse MEB, Magder LS, Petri M. The clinical utility of measuring complement and anti-dsDNA antibodies during pregnancy in patients with systemic lupus erythematosus. J Rheumatol. 2011;38(6):1012–1016.
   PubMed Web of Science ®Google Scholar
• Borella E, Lojacono A, Gatto M, et al. Predictors of maternal and fetal complications in SLE patients: a prospective study. Immunol Res. 2014;60(2–3):170–176.
   PubMed Web of Science ®Google Scholar
• Moroni G, Quaglini S, Banfi G, et al. Pregnancy in lupus nephritis. Am J Kidney Dis. 2002;40(4):713–720.
   PubMed Web of Science ®Google Scholar
• Clark CA, Spitzer KA, Laskin CA. Decrease in pregnancy loss rates in patients with systemic lupus erythematosus over a 40-year period. J Rheumatol. 2005;32(9):1709–1712.
   PubMed Web of Science ®Google Scholar
• Wu J, Zhang W-H, Ma J, et al. Prediction of fetal loss in Chinese pregnant patients with systemic lupus erythematosus: a retrospective cohort study. BMJ Open. 2019;9(2):e023849.
   PubMedGoogle Scholar
• Wagner SJ, Craici I, Reed D, et al. Maternal and foetal outcomes in pregnant patients with active lupus nephritis. Lupus. 2009;18(4):342–347.
   PubMed Web of Science ®Google Scholar
• Al Arfaj AS, Khalil N. Pregnancy outcome in 396 pregnancies in patients with SLE in Saudi Arabia. Lupus. 2010;19(14):1665–1673.
   PubMed Web of Science ®Google Scholar
• Gladman DD, Tandon A, Ibañez D, et al. The effect of lupus nephritis on pregnancy outcome and fetal and maternal complications. J Rheumatol. 2010;37(4):754–758.
   PubMed Web of Science ®Google Scholar
• Saavedra MA, Cruz-Reyes C, Vera-Lastra O, et al. Impact of previous lupus nephritis on maternal and fetal outcomes during pregnancy. Clin Rheumatol. 2012;31(5):813–819.
   PubMed Web of Science ®Google Scholar
• Oishi Y, Ikeuchi H, Hamatani H, et al. Pregnancy outcomes in patients with systemic lupus erythematosus with or without a history of lupus nephritis. Clin Exp Nephrol. 2021;25(8):835–843.
   PubMedGoogle Scholar
• Moroni G, Doria A, Giglio E, et al. Fetal outcome and recommendations of pregnancies in lupus nephritis in the 21st century. A prospective multicenter study. J Autoimmun. 2016;74:6–12.
   PubMed Web of Science ®Google Scholar
• Andreoli L, Bertsias GK, Agmon-Levin N, et al., EULAR recommendations for women’s health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome. Ann Rheum Dis. 76(3): 476–485. 2017.
   PubMed Web of Science ®Google Scholar
• Askanase AD, Friedman DM, Copel J, et al. Spectrum and progression of conduction abnormalities in infants born to mothers with anti-SSA/Ro-SSB/La antibodies. Lupus. 2002;11:145–151.
   PubMed Web of Science ®Google Scholar
• Cv A, Keyes KM, Wapner RJ. Pre-eclampsia rates in the United States, 1980-2010: age-period-cohort analysis. BMJ. 2013;347:f6564.
   PubMedGoogle Scholar
• EV A, Palmsten K, Sjöwall C, et al. What to expect when expecting with Systemic Lupus Erythematosus (SLE): a population-based study of maternal and fetal outcomes in SLE and pre-SLE. Arthritis Care Res (Hoboken). 2016;68:988–994.
   PubMedGoogle Scholar
• Clowse MEB, Jamison M, Myers E, et al. A national study of the complications of lupus in pregnancy. Am J Obstet Gynecol. 2008;199:127.e1–6.
   PubMed Web of Science ®Google Scholar
• Soubassi L, Haidopoulos D, Sindos M, et al. Pregnancy outcome in women with pre-existing lupus nephritis. J Obstet Gynaecol. 2004;24:630–634.
   PubMedGoogle Scholar
• Rahman FZ, Rahman J, Al-Suleiman SA, et al. Pregnancy outcome in lupus nephropathy. Arch Gynecol Obstet. 2005;271(3):222–226.
   PubMedGoogle Scholar
• Carmona F, Font J, Moga I, et al. Class III-IV proliferative lupus nephritis and pregnancy: a study of 42 cases. Am J Reprod Immunol. 2005;53(4):182–188.
   PubMed Web of Science ®Google Scholar
• Otaduy C, Gobbi CA, Álvarez A, et al. Is lupus nephritis a prognosis factor for pregnancy? Maternal and foetal outcomes. Reumatol Clin. 2021;S21173-5743:21)00165–9.
   Google Scholar
• Chen Y, Li K, Zhang H, et al. Good pregnancy outcomes in lupus nephritis patients with complete renal remission. Nephrol Dial Transplant. 2021. DOI:https://doi.org/10.1093/ndt/gfab289.
   Google Scholar
• Ruiz-Irastorza G, Crowther M, Branch W, et al. Antiphospholipid syndrome. Lancet. 2010;376(9751):1498–1509.
   PubMed Web of Science ®Google Scholar
• Clowse MEB, Magder LS, Witter F, et al. The impact of increased lupus activity on obstetric outcomes. Arthritis Rheum. 2005;52(2):514–521.
   PubMed Web of Science ®Google Scholar
• Wu J, Ma J, Zhang W-H, et al. Management and outcomes of pregnancy with or without lupus nephritis: a systematic review and meta-analysis. Ther Clin Risk Manag. 2018;14:885–901.
   PubMed Web of Science ®Google Scholar
• Clark EAS, Silver RM, Branch DW. Do antiphospholipid antibodies cause preeclampsia and HELLP syndrome? Curr Rheumatol Rep. 2007;9(3):219–225.
   PubMedGoogle Scholar
• Petri M. Prospective study of systemic lupus erythematosus pregnancies. Lupus. 2004;13(9):688–689.
   PubMed Web of Science ®Google Scholar
• Kim MY, Guerra MM, Kaplowitz E, et al. Complement activation predicts adverse pregnancy outcome in patients with systemic lupus erythematosus and/or antiphospholipid antibodies. Ann Rheum Dis. 2018;77(4):549–555.
   PubMed Web of Science ®Google Scholar
• Farrington CA. Kidney imaging and biopsy in pregnancy. Adv Chronic Kidney Dis. 2020;27(6):525–530.
   PubMedGoogle Scholar
• Piccoli GB, Daidola G, Attini R, et al. Kidney biopsy in pregnancy: evidence for counselling? A systematic narrative review. Bjog. 2013;120(4):412–427.
   PubMed Web of Science ®Google Scholar
• Walker JJ. Pre-eclampsia. Lancet. 2000;356(9237):1260–1265.
   PubMed Web of Science ®Google Scholar
• Sibai BM, Mercer B, Sarinoglu C. Severe preeclampsia in the second trimester: recurrence risk and long-term prognosis. Am J Obstet Gynecol. 1991;165(5):1408–1412.
   PubMedGoogle Scholar
• van Rijn BB, Hoeks LB, Bots ML, et al. Outcomes of subsequent pregnancy after first pregnancy with early-onset preeclampsia. Am J Obstet Gynecol. 2006;195(3):723–728.
   PubMed Web of Science ®Google Scholar
• Ghulmiyyah L, Sibai B. Maternal mortality from preeclampsia/eclampsia. Semin Perinatol. 2012;36(1):56–59.
   PubMed Web of Science ®Google Scholar
• Wu P, Haththotuwa R, Kwok CS, et al. Preeclampsia and future cardiovascular health: a systematic review and meta-analysis. Circ Cardiovasc Qual Outcomes. 2017;10(2). DOI:https://doi.org/10.1161/CIRCOUTCOMES.116.003497.
   PubMed Web of Science ®Google Scholar
• McDonald SD, Han Z, Walsh MW, et al. Kidney disease after preeclampsia: a systematic review and meta-analysis. Am J Kidney Dis. 2010;55(6):1026–1039.
   PubMed Web of Science ®Google Scholar
• Gianfreda D, Quaglini S, Frontini G, et al. Does pregnancy have any impact on long term damage accrual and on the outcome of lupus nephritis? J Autoimmun. 2017;84:46–54.
   PubMed Web of Science ®Google Scholar
• Vikse BE, Irgens LM, Karumanchi SA, et al. Familial factors in the association between preeclampsia and later ESRD. Clin J Am Soc Nephrol. 2012;7(11):1819–1826.
   PubMedGoogle Scholar
• C-c W, Chen S-H, C-h H, et al. End-stage renal disease after hypertensive disorders in pregnancy. Am J Obstet Gynecol. 2014;210(2):147.e1–8.
   Google Scholar
• Covella B, Vinturache AE, Cabiddu G, et al. A systematic review and meta-analysis indicates long-term risk of chronic and end-stage kidney disease after preeclampsia. Kidney Int. 2019;96(3):711–727.
   PubMedGoogle Scholar
• Moyer A, Chakravarty EF. Management of Pregnancy in Lupus. Rheum Dis Clin North Am. 2021;47(3):441–455.
   PubMedGoogle Scholar
• Sammaritano LR, Bermas BL, Chakravarty EE, et al. 2020 American College of Rheumatology Guideline for the management of reproductive health in rheumatic and musculoskeletal diseases. Arthritis Rheumatol. 2020;72(4):529–556.
   PubMed Web of Science ®Google Scholar
• Al Maimouni H, Gladman DD, Ibañez D, et al. Switching treatment between mycophenolate mofetil and azathioprine in lupus patients: indications and outcomes. Arthritis Care Res (Hoboken). 2014;66(12):1905–1909.
   PubMed Web of Science ®Google Scholar
• Ponticelli C, Moroni G. Immunosuppression in pregnant women with systemic lupus erythematosus. Expert Rev Clin Immunol. 2015;11(5):549–552.
   PubMed Web of Science ®Google Scholar
• Henderson JT, Vesco KK, Senger CA, et al. Aspirin use to prevent preeclampsia and related morbidity and mortality: updated evidence report and systematic review for the US Preventive services task force. JAMA. 2021;326(12):1192–1206.
   PubMedGoogle Scholar
• Rolnik DL, Wright D, Poon LC, et al. Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia. N Engl J Med. 2017;377(7):613–622.
   PubMed Web of Science ®Google Scholar
• Duley L, Henderson-Smart DJ, Meher S, et al. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev. 2007;(2):CD004659. DOI:https://doi.org/10.1002/14651858.CD004659.pub2.
   Google Scholar
• CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group. CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. Lancet. 1994;343(8898):619–629.
   PubMed Web of Science ®Google Scholar
• Hoffman MK, Goudar SS, Kodkany BS, et al. Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (ASPIRIN): a randomised, double-blind, placebo-controlled trial. Lancet. 2020;395(10220):285–293.
   PubMed Web of Science ®Google Scholar
• Schreiber K, Hunt BJ. Managing antiphospholipid syndrome in pregnancy. Thromb Res. 2019;Suppl 181:S41–6.
   PubMedGoogle Scholar
• Eudy AM, Siega-Riz AM, Engel SM, et al. Effect of pregnancy on disease flares in patients with systemic lupus erythematosus. Ann Rheum Dis. 2018;77(6):855–860.
   PubMed Web of Science ®Google Scholar
• Davis-Porada J, Kim MY, Guerra MM, et al. Low frequency of flares during pregnancy and post-partum in stable lupus patients. Arthritis Res Ther. 2020;22(1):52.
   PubMed Web of Science ®Google Scholar
• Levy RA, Vilela VS, Cataldo MJ, et al. Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study. Lupus. 2001;10(6):401–404.
   PubMed Web of Science ®Google Scholar
• Clowse MEB, Magder L, Witter F, et al. Hydroxychloroquine in lupus pregnancy. Arthritis Rheum. 2006;54(11):3640–3647.
   PubMed Web of Science ®Google Scholar
• Hofmeyr GJ, Manyame S, Medley N, et al. Calcium supplementation commencing before or early in pregnancy, for preventing hypertensive disorders of pregnancy. Cochrane Database Syst Rev. 2019;9:CD011192.
   PubMedGoogle Scholar
• Regal JF, Gilbert JS, Burwick RM. The complement system and adverse pregnancy outcomes. Mol Immunol. 2015;67(1):56–70.
   PubMed Web of Science ®Google Scholar
• Magee LA, Pels A, Helewa M, et al. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary. J Obstet Gynaecol Can. 2014;36(5):416–441.
   PubMedGoogle Scholar
• NICE guidance
   Google Scholar
• Duley L, Meher S, Jones L. Drugs for treatment of very high blood pressure during pregnancy. Cochrane Database Syst Rev. 2013;CD001449. DOI:https://doi.org/10.1002/14651858.CD001449.pub3
   PubMed Web of Science ®Google Scholar
• WHO. Recommendations for drug treatment for severe hypertension in pregnancy. (Geneva: World Health Organization). 2018. PMID 30629932.
   Google Scholar
• Duley L, Gülmezoglu AM, Henderson-Smart DJ, et al. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. Cochrane Database Syst Rev. 2010;(11):CD000025. DOI:https://doi.org/10.1002/14651858.CD000025.pub2.
   Google Scholar
• Sibai BM. Management of late preterm and early-term pregnancies complicated by mild gestational hypertension/pre-eclampsia. Semin Perinatol. 2011;35(5):292–296.
   PubMed Web of Science ®Google Scholar
• Koopmans CM, Bijlenga D, Groen H, et al. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks’ gestation (HYPITAT): a multicentre, open-label randomised controlled trial. Lancet. 2009;374(9694):979–988.
   PubMed Web of Science ®Google Scholar
• Churchill D, Duley L, Thornton JG, et al. Interventionist versus expectant care for severe pre-eclampsia between 24 and 34 weeks’ gestation. Cochrane Database Syst Rev. 2013;7:CD003106.
   PubMed Web of Science ®Google Scholar
• Vigil-De Gracia P, Reyes Tejada O, Calle Miñaca A, et al. Expectant management of severe preeclampsia remote from term: the MEXPRE Latin Study, a randomized, multicenter clinical trial. Am J Obstet Gynecol. 2013;209(5):425.e1–8.
   Web of Science ®Google Scholar
• WHO recommendations on drug treatment for non-severe hypertension. WHO recommendations on drug treatment for non-severe hypertension in pregnancy. 2020.
   Google Scholar
• Garovic VD, Wagner SJ, Turner ST, et al. Urinary podocyte excretion as a marker for preeclampsia. Am J Obstet Gynecol. 2007;196(4):320.e1–7.
   Google Scholar